DC
MDT icon

Davenport & Co’s Medtronic MDT Stock Holding History

Davenport & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-329,600
Closed -$26.6M – 1074
2023
Q1 		$26.6M Buy
329,600
+1,100
+0.3% +$89.7K 0.21% 118
2022
Q4 		$25.5M Buy
+328,500
New +$26.6M 0.21% 116

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
CCMIC
Cardinal Capital Management Inc (Canada) Winnipeg, Manitoba, Canada $4.13B AUM 31.23% 1-Year Est. Return

Davenport & Co's MDT Position: Q2 2026 in Review

Davenport & Co increased its Medtronic (MDT) stake by 1.2% in Q2 2026, buying an estimated $1.02M and bringing the position to 1,098,548 shares worth $86.7M. The position accounts for 0.43% of the portfolio, ranked #79.

Davenport & Co first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $167M in Q1 2022. 420 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Davenport & Co held 1,098,548 shares of Medtronic worth $86.7M as of Q2 2026.
  • Davenport & Co bought 12,649 Medtronic shares in Q2 2026, an estimated $1.02M.
  • Medtronic made up 0.43% of Davenport & Co's portfolio in Q2 2026, its #79 holding.
  • Davenport & Co first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Medtronic position peaked at $167M in Q1 2022.
  • 420 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.